AbbVie Inc (4AB)

138.86
+0.98(+0.71%)
  • Volume:
    2,582
  • Bid/Ask:
    138.60/138.86
  • Day's Range:
    136.76 - 139.72

4AB Overview

Prev. Close
137.88
Day's Range
136.76-139.72
Revenue
-
Open
138.44
52 wk Range
89.51-164
EPS
-
Volume
2,582
Market Cap
245.73B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
4,111
P/E Ratio
-
Beta
-
1-Year Change
40.53%
Shares Outstanding
1,768,096,495
Next Earnings Date
-
What is your sentiment on AbbVie?
or
Market is currently closed. Voting is open during market hours.

AbbVie Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

AbbVie Inc Analysis

AbbVie Inc Company Profile

AbbVie Inc Company Profile

Employees
50000
  • Type:Equity
  • Market:Germany
  • ISIN:US00287Y1091
  • WKN:A1J84E

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyStrong BuySellStrong Buy
  • in spite of the volatility I'm still in but, with a watchful eye. What is the prognosis? I'd like to hear.
    1
    • oouch
      0
      • bought some puts. looking for a nice break down.
        0
        • Yes, all the way down below 100. Cheers
          1
          • On friday we are gonna have a new high after earning report
            1
            • Oh yes; you have it
              1
            • welp, this comment didn't age well. I'm gonna wait till this goes a bit up so I lose less on my call options 🤷‍♂️
              1
            • get into this solid company
              0
          • Finally. just all the way down under 100
            7
            • Why do you say that? Cheers.
              0
            • Under $100? Are you high right now? Forward P/E is at 13 right now, it’s underpriced. 🤣🤣🤣
              0
          • Why are we falling this steep today? Cheers.
            1
            • For the fiscal year ended 31 December 2021, Romeo Power Inc revenues increased 87% to $16.8M. Net income totaled $10M vs. loss of $7.6M. Revenues reflect Product revenues increase from $2.9M to $12.4M, Service revenues increase of 51% to $4.4M. Net Income reflects FV Adjustments of Financial Investments increase from $34.2M to $126.4M (income), OTHER EXPENSE decrease from $3.9M (expense) to $0K.
              1
              • 177 in few days coming
                1
                • May be tomorrow...
                  0
              • Are we gonna hold at 16+
                0
                • I meant 160+....now I'm greedily looking for more.
                  0